Standard Motion · S4M-13656 · Session 4
Novel Treatment for Breast Cancer
The motion
That the Parliament understands that the use of intrabeam radiotherapy has the potential to substantially reduce the burden of radiotherapy in the treatment of women with breast cancer; recognises that this novel treatment was first tried at the Middlesex Hospital in 1998 and is now being undertaken routinely in the US, Germany, Australia, France and other countries; welcomes the guidance issued by the National Institute for Health and Care Excellence in July 2014 recommending a single dose intrabeam radiotherapy at the time of surgery to replace 15 sessions of post-operative radiotherapy; appreciates that this decision was taken after a randomised controlled trial led by University College London, the TARGIT-A trial, which was published in 2010 and showed at five year follow up in 2014 that results were not inferior to the previous 15 session treatment, and invites the Scottish Government to support the implementation of this new therapy for the benefit of patients and in the expectation of substantial savings in resource to the NHS.
Signatures by party
20 MSPs besides the lodger · 5 from other partiesLab 15SNP 3Con 2
Party on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions
Vote
No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.
Supporters
20 MSPsLab 15 SNP 3 Con 2
Show all 20 supporters by party
Lab 15
- Jackie Baillie
- Claire Baker
- Jayne Baxter
- Sarah Boyack
- Mary Fee
- Patricia Ferguson
- Neil Findlay
- Hanzala Malik
- Margaret McCulloch
- Margaret McDougall
- Michael McMahon
- Anne McTaggart
- Elaine Murray
- Elaine Smith
- David Stewart
SNP 3
Con 2
Party shown is each supporter’s party when the motion was published.
In the Official Report
No contribution in the Official Report cites S4M-13656 by reference.